Concepedia

Kim Hung Lo

KH

32

Publications

4.5K

Citations

21

H-Index

1997

Active since

Affiliations

Janssen (United States)(Current)

University of Cincinnati

University of Pennsylvania

Cleveland Clinic

University of California San Diego

Kim Hung Lo is an author at Janssen (United States) specializing in medicine, neurology, and psychiatry.

Top concepts

Publications per year

1997–2024

32

Publications

32

Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure

Eugene S. Chung, Milton Packer, Kim Hung Lo et al. · Circulation · 2003 · 1.6K citations

Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement

Robert P. Baughman, Marjolein Drent, Mani S. Kavuru et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 702 citations

A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma

Sally E. Wenzel, Peter J. Barnes, Eugene R. Bleecker et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 457 citations

The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, Charles Fogarty, Steven G. Kelsen et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 426 citations

Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial

Marc A. Judson, Robert P. Baughman, Ulrich Costabel et al. · European Respiratory Journal · 2008 · 319 citations · Full text

Rows per page

1–5 of 32